Discounted Cash Flow (DCF) Analysis Unlevered
Dolby Laboratories, Inc. (DLB)
$83.36
+0.75 (+0.91%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 1,171.92 | 1,241.62 | 1,161.79 | 1,281.26 | 1,253.79 | 1,277.79 | 1,302.25 | 1,327.18 | 1,352.59 | 1,378.48 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
EBITDA | 393.79 | 367.25 | 330.52 | 460.15 | 319.47 | 391.07 | 398.55 | 406.18 | 413.96 | 421.88 |
EBITDA (%) | ||||||||||
EBIT | 312.51 | 282.12 | 239.65 | 347.39 | 215.86 | 292.22 | 297.81 | 303.52 | 309.33 | 315.25 |
EBIT (%) | ||||||||||
Depreciation | 81.28 | 85.12 | 90.88 | 112.76 | 103.61 | 98.85 | 100.74 | 102.67 | 104.63 | 106.63 |
Depreciation (%) |
Balance Sheet Data
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Total Cash | 1,096.20 | 916.36 | 1,118.82 | 1,264.22 | 809.34 | 1,090.89 | 1,111.77 | 1,133.06 | 1,154.75 | 1,176.85 |
---|---|---|---|---|---|---|---|---|---|---|
Total Cash (%) | ||||||||||
Account Receivables | 139.59 | 385.55 | 341.70 | 414.92 | 419.69 | 353.26 | 360.03 | 366.92 | 373.94 | 381.10 |
Account Receivables (%) | ||||||||||
Inventories | 26.21 | 32.33 | 25.55 | 10.97 | 23.55 | 24.98 | 25.45 | 25.94 | 26.44 | 26.94 |
Inventories (%) | ||||||||||
Accounts Payable | 21.92 | 15.21 | 12.62 | 17.78 | 14.17 | 17.12 | 17.45 | 17.78 | 18.12 | 18.47 |
Accounts Payable (%) | ||||||||||
Capital Expenditure | -85.36 | -113.54 | -68.99 | -54.45 | -59.46 | -80.14 | -81.67 | -83.24 | -84.83 | -86.45 |
Capital Expenditure (%) |
Weighted Average Cost Of Capital
Share price | $ 83.36 |
---|---|
Beta | 1.005 |
Diluted Shares Outstanding | 101.98 |
Cost of Debt | |
Tax Rate | 14.49 |
After-tax Cost of Debt | 0.66% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.348 |
Total Debt | 50.94 |
Total Equity | 8,501.30 |
Total Capital | 8,552.24 |
Debt Weighting | 0.60 |
Equity Weighting | 99.40 |
Wacc |
Build Up Free Cash
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 1,171.92 | 1,241.62 | 1,161.79 | 1,281.26 | 1,253.79 | 1,277.79 | 1,302.25 | 1,327.18 | 1,352.59 | 1,378.48 |
---|---|---|---|---|---|---|---|---|---|---|
EBITDA | 393.79 | 367.25 | 330.52 | 460.15 | 319.47 | 391.07 | 398.55 | 406.18 | 413.96 | 421.88 |
EBIT | 312.51 | 282.12 | 239.65 | 347.39 | 215.86 | 292.22 | 297.81 | 303.52 | 309.33 | 315.25 |
Tax Rate | 60.93% | 9.62% | 3.48% | 12.49% | 14.49% | 20.20% | 20.20% | 20.20% | 20.20% | 20.20% |
EBIAT | 122.10 | 254.98 | 231.30 | 304 | 184.59 | 233.19 | 237.65 | 242.20 | 246.83 | 251.56 |
Depreciation | 81.28 | 85.12 | 90.88 | 112.76 | 103.61 | 98.85 | 100.74 | 102.67 | 104.63 | 106.63 |
Accounts Receivable | - | -245.96 | 43.85 | -73.23 | -4.76 | 66.42 | -6.76 | -6.89 | -7.02 | -7.16 |
Inventories | - | -6.13 | 6.78 | 14.59 | -12.58 | -1.43 | -0.48 | -0.49 | -0.50 | -0.51 |
Accounts Payable | - | -6.71 | -2.60 | 5.16 | -3.61 | 2.95 | 0.33 | 0.33 | 0.34 | 0.35 |
Capital Expenditure | -85.36 | -113.54 | -68.99 | -54.45 | -59.46 | -80.14 | -81.67 | -83.24 | -84.83 | -86.45 |
UFCF | 118.03 | -32.23 | 301.22 | 308.82 | 207.79 | 319.84 | 249.80 | 254.58 | 259.46 | 264.42 |
WACC | ||||||||||
PV UFCF | 295.33 | 212.98 | 200.42 | 188.60 | 177.48 | |||||
SUM PV UFCF | 1,074.82 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 8.30 |
Free cash flow (t + 1) | 269.71 |
Terminal Value | 4,281.15 |
Present Value of Terminal Value | 2,873.55 |
Intrinsic Value
Enterprise Value | 3,948.36 |
---|---|
Net Debt | -569.18 |
Equity Value | 4,517.55 |
Shares Outstanding | 101.98 |
Equity Value Per Share | 44.30 |